- Home
- PRSU vs GHRS Comparison
PRSU vs GHRS Comparison
Compare PRSU & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRSU | GHRS |
|---|---|---|
| Founded | 1926 | 2018 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 960.2M | 892.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRSU | GHRS |
|---|---|---|
| Price | $34.35 | $12.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $31.67 | $30.11 |
| AVG Volume (30 Days) | 228.0K | ★ 235.7K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 902.95 | N/A |
| EPS | ★ 10.75 | N/A |
| Revenue | ★ $441,143,000.00 | N/A |
| Revenue This Year | $26.24 | N/A |
| Revenue Next Year | $8.01 | N/A |
| P/E Ratio | $3.38 | ★ N/A |
| Revenue Growth | ★ 4.63 | N/A |
| 52 Week Low | $26.66 | $6.85 |
| 52 Week High | $43.83 | $20.50 |
Technical Indicators
Market Signals| Indicator | PRSU | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 40.90 |
| Support Level | $35.24 | $12.04 |
| Resistance Level | $37.85 | $13.33 |
| Average True Range (ATR) | 1.01 | 0.79 |
| MACD | -0.13 | -0.13 |
| Stochastic Oscillator | 17.69 | 19.50 |
Price Performance
Historical ComparisonAbout PRSU Pursuit Attractions and Hospitality Inc.
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.